MacroGenics Statistics
Total Valuation
MacroGenics has a market cap or net worth of $85.80 million. The enterprise value is -$30.87 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MacroGenics has 63.09 million shares outstanding. The number of shares has increased by 1.19% in one year.
| Current Share Class | 63.09M |
| Shares Outstanding | 63.09M |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 3.09% |
| Owned by Institutions (%) | 70.61% |
| Float | 51.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| Forward PS | 1.91 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.47.
| Current Ratio | 3.28 |
| Quick Ratio | 2.97 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,362.36 |
Financial Efficiency
Return on equity (ROE) is -60.25% and return on invested capital (ROIC) is -48.42%.
| Return on Equity (ROE) | -60.25% |
| Return on Assets (ROA) | -26.29% |
| Return on Invested Capital (ROIC) | -48.42% |
| Return on Capital Employed (ROCE) | -58.80% |
| Revenue Per Employee | $451,760 |
| Profits Per Employee | -$163,672 |
| Employee Count | 341 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 36.17 |
Taxes
In the past 12 months, MacroGenics has paid $944,000 in taxes.
| Income Tax | 944,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 2.19, so MacroGenics's price volatility has been higher than the market average.
| Beta (5Y) | 2.19 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 39.89 |
| Average Volume (20 Days) | 378,677 |
Short Selling Information
The latest short interest is 6.09 million, so 9.66% of the outstanding shares have been sold short.
| Short Interest | 6.09M |
| Short Previous Month | 5.68M |
| Short % of Shares Out | 9.66% |
| Short % of Float | 11.79% |
| Short Ratio (days to cover) | 10.76 |
Income Statement
In the last 12 months, MacroGenics had revenue of $154.05 million and -$55.81 million in losses. Loss per share was -$0.89.
| Revenue | 154.05M |
| Gross Profit | -38.98M |
| Operating Income | -99.45M |
| Pretax Income | -136.37M |
| Net Income | -55.81M |
| EBITDA | -91.98M |
| EBIT | -99.45M |
| Loss Per Share | -$0.89 |
Full Income StatementBalance Sheet
The company has $154.14 million in cash and $37.47 million in debt, giving a net cash position of $116.68 million or $1.85 per share.
| Cash & Cash Equivalents | 154.14M |
| Total Debt | 37.47M |
| Net Cash | 116.68M |
| Net Cash Per Share | $1.85 |
| Equity (Book Value) | 79.12M |
| Book Value Per Share | 1.25 |
| Working Capital | 126.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.62 million and capital expenditures -$2.78 million, giving a free cash flow of -$72.40 million.
| Operating Cash Flow | -69.62M |
| Capital Expenditures | -2.78M |
| Free Cash Flow | -72.40M |
| FCF Per Share | -$1.15 |
Full Cash Flow StatementMargins
Gross margin is -25.30%, with operating and profit margins of -64.56% and -36.23%.
| Gross Margin | -25.30% |
| Operating Margin | -64.56% |
| Pretax Margin | -35.62% |
| Profit Margin | -36.23% |
| EBITDA Margin | -59.71% |
| EBIT Margin | -64.56% |
| FCF Margin | n/a |
Dividends & Yields
MacroGenics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.19% |
| Shareholder Yield | -1.19% |
| Earnings Yield | -65.05% |
| FCF Yield | -84.37% |
Analyst Forecast
The average price target for MacroGenics is $5.33, which is 286.23% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.33 |
| Price Target Difference | 286.23% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | -9.96% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MacroGenics has an Altman Z-Score of -6.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.36 |
| Piotroski F-Score | 2 |